Canada markets close in 5 hours 48 minutes
  • S&P/TSX

    19,114.82
    +51.91 (+0.27%)
     
  • S&P 500

    3,899.90
    -11.84 (-0.30%)
     
  • DOW

    31,438.51
    -62.17 (-0.20%)
     
  • CAD/USD

    0.7747
    -0.0012 (-0.15%)
     
  • CRUDE OIL

    107.16
    -0.46 (-0.43%)
     
  • BTC-CAD

    26,761.14
    -1,051.66 (-3.78%)
     
  • CMC Crypto 200

    451.78
    -10.01 (-2.17%)
     
  • GOLD FUTURES

    1,828.40
    -1.90 (-0.10%)
     
  • RUSSELL 2000

    1,764.06
    -1.67 (-0.09%)
     
  • 10-Yr Bond

    3.1580
    +0.0330 (+1.06%)
     
  • NASDAQ

    11,536.45
    -71.17 (-0.61%)
     
  • VOLATILITY

    28.20
    +0.97 (+3.56%)
     
  • FTSE

    7,235.32
    +26.51 (+0.37%)
     
  • NIKKEI 225

    26,871.27
    +379.30 (+1.43%)
     
  • CAD/EUR

    0.7321
    -0.0025 (-0.34%)
     

Stocks in play: Helix BioPharma Corp

  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Is pleased to provide a corporate update on initiatives that were undertaken by the Company in 2021. During the second half of 2021, the Company initiated efforts to validate Helix; an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, and its lead clinical program with external stakeholders to bring in an outside perspective to the company's strategy and future. Helix BioPharma Corp shares T.HBP are trading unchanged at $0.30.

Read:

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting